|
gptkbp:instance_of
|
gptkb:Company
|
|
gptkbp:bfsLayer
|
3
|
|
gptkbp:bfsParent
|
gptkb:Amgen
|
|
gptkbp:focus_area
|
gptkb:Company
Life Sciences
|
|
gptkbp:founded
|
gptkb:2004
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Amgen Ventures
|
|
gptkbp:investment
|
gptkb:Molecular_Templates
gptkb:temple
gptkb:Zymeworks
gptkb:hospital
gptkb:Insurance_Company
gptkb:Cure_Vac
gptkb:battle
Growth Stage
Diagnostics
Early Stage
Strategic Partnerships
Therapeutics
Follow-On Investments
Co-Investments
Cure Metrix
Direct Investments
$1 M to $10 M
$10 M to $50 M
$50 M+
|
|
gptkbp:key_people
|
gptkb:Robert_A._Bradway
gptkb:David_A._Scott
gptkb:Michele_A._H._Lee
gptkb:Kathy_H._H._Lee
gptkb:James_C._Mullen
gptkb:Michael_A._Mc_Ginnis
gptkb:John_C._Lechleiter
gptkb:Kevin_O'_Leary
David Mott
Lori A. H. Lee
Megan H. H. Lee
|
|
gptkbp:location
|
gptkb:Thousand_Oaks,_California
|
|
gptkbp:parent_company
|
gptkb:Amgen_Inc.
|
|
gptkbp:production_company
|
gptkb:Freenome
gptkb:Kymab
gptkb:Synthego
GRAIL
Scribe Therapeutics
|
|
gptkbp:website
|
https://www.amgenventures.com
|